CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,100,000
- in 1 filing
Net −$3,100,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-15 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +6,830 | $10.85 | $74K | 240,754 |
| 2025-04-15 | Lewis William Chair and CEO | Sale 10b5-1 | −3,334 | $69.62 | $232K | 237,420 |
| 2025-04-15 | Lewis William Chair and CEO | Sale 10b5-1 | −2,896 | $70.54 | $204K | 234,524 |
| 2025-04-15 | Lewis William Chair and CEO | Sale 10b5-1 | −600 | $71.30 | $43K | 233,924 |
| 2025-04-15 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −6,830 | 177,650 | ||
| 2025-04-01 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +6,830 | $10.85 | $74K | 240,754 |
| 2025-04-01 | Lewis William Chair and CEO | Sale 10b5-1 | −3,021 | $72.29 | $218K | 237,733 |
| 2025-04-01 | Lewis William Chair and CEO | Sale 10b5-1 | −772 | $73.44 | $57K | 236,961 |
| 2025-04-01 | Lewis William Chair and CEO | Sale 10b5-1 | −2,232 | $74.78 | $167K | 234,729 |
| 2025-04-01 | Lewis William Chair and CEO | Sale 10b5-1 | −805 | $75.26 | $61K | 233,924 |
| 2025-04-01 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −6,830 | 184,480 | ||
| 2025-03-17 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +18,750 | $22.76 | $427K | 352,936 |
| 2025-03-17 | Lewis William Chair and CEO | Sale 10b5-1 | −4,727 | $75.91 | $359K | 348,209 |
| 2025-03-17 | Lewis William Chair and CEO | Sale 10b5-1 | −5,907 | $76.87 | $454K | 342,302 |
| 2025-03-17 | Lewis William Chair and CEO | Sale 10b5-1 | −8,116 | $77.79 | $631K | 334,186 |
| 2025-03-17 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +6,830 | $10.85 | $74K | 240,754 |
| 2025-03-17 | Lewis William Chair and CEO | Sale 10b5-1 | −2,023 | $76.00 | $154K | 238,731 |
| 2025-03-17 | Lewis William Chair and CEO | Sale 10b5-1 | −2,070 | $77.01 | $159K | 236,661 |
| 2025-03-17 | Lewis William Chair and CEO | Sale 10b5-1 | −2,737 | $77.83 | $213K | 233,924 |
| 2025-03-17 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −18,750 | 0 |
Page 27 of 42 · 826 trades